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Abstract We identified three overlapping human expressed se- 
quence tags with significant homology to the E. coli CIpP amino 
sequence by screening the EMBL nncleotide database. With this 
sequence information we appfied 5' and 3"-rapid amplification of 
cDNA ends (RACE) to amplify and sequence human clpP cDNA 
in two overlapping fragments. The open reading frame encodes 
a 277 amino acid long precursor polypeptide. Two CIpP specific 
motifs surrounding the active site residues are present and exten- 
sive homology to ClpP's from other organisms was observed. 
Northern blotting showed high relative expression levels of clpP 
mRNA in skeletal muscle, intermediate levels in heart, liver and 
pancreas, and low levels in brain, placenta, lung and kidney. By 
analysis of human/rodent cell hybrids the human clpP gene was 
assigned to chromosome 19. 
K~y words: ATP-dependent protease; Protein degradation; 
ClaP; eDNA sequence; Tissue-specific expression, 
H,,mo sapiens 
I. Introduction 
&TP-dependent proteases have first been identified in E. coli. 
Two such proteases, Lon (also called La) and CIpAP (also 
re:erred to as Ti), have been characterized (for recent reviews 
se;: [1,2]. Both are involved in ATP-dependent degradation of
abnormal (i.e. incorrectly folded or unfolded) proteins. Homol- 
o~s of the Lon protease have been identified in other bacteria 
al~d mitochondria [3,4]. ClpAP protease consists of a regulatory 
u~it (ClpA) with chaperone characteristics which contains the 
ATPase domain [5] and a proteolytic subunit (ClpP) [6]. The 
CpA subunit belongs to a family of proteins with at least hree 
ht,mologs in E. coli [7] and homologs in eucaryots (Hsp78, 
H;pl04 [8,9]. In E. coli, CIpP has been found complexed with 
either ClpA or the homologous CIpX [7]. It appears that, de- 
pt:ndent on which of the regulatory subunits ClpP is complexed 
w~th, different substrates are processed proteolytically. Re- 
c~ ntly, it has been shown that clpA can complement the chaper- 
o~e function of DnaK [10]. This suggests that the function of 
tte ATP-ase subunit in the CIpAP complex may be to unfold 
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the protein and present it to the protease subunit. The ClpP 
subunit is organized in a tetradecamer consisting of two hep- 
tameric rings [11]. ClpA or ClpX are present as dimers which 
assemble into a hexamer upon substrate binding followed by 
complex formation with the ClpP double heptamer. 
Sequences for bacterial and chloroplast clpP genes have been 
reported. Immunological experiments indicated the presence of 
CIpP homologs in mammalian cells [12]. We are interested in 
inherited efects in enzymes involved in mitochondrial fl-oxida- 
tion of fatty acids. Many of the mutations in medium-chain 
acyl-CoA dehydrogenase (MCAD) deficiency cause impaired 
folding of the proteins [13]. Impaired folding results in prema- 
ture degradation of the mutant MCAD polypeptides and we 
have shown that the availability of hsp60/hspl0 chaperones can 
modulate the level of M CAD enzyme present [13,14]. Recently 
it has been suggested that an interplay exists between the hsp60/ 
hspl0 system and CIpP protease [15]. This prompted us to 
determine the eDNA sequence of human ClpP in order to be 
able to investigate its possible contribution ofproteins carrying 
folding mutations. 
2. Materials and methods 
2.1. Sequencing of human clpP eDNA 
Sequence information from three overlapping human expressed se- 
quence tags (accession: T34278, T04899, and T31415) was used to 
locate a clpP-specific sense (CGGGGCCAAGCCACAGACAT) and 
an antisense (TGGACCAGAACCTTGTCTAAGATGC) primers. 
Adaptor ligated cDNAs from human placenta mRNA and total RNA 
from cultured human fibroblast cells were produced using the Mara- 
thon eDNA kit (Clonetech, Palo Alto). Subsequently, rapid amplifica- 
tion of cDNA ends (RACE) was performed using the clpP specific 
primers and the adaptor primer included in the kit. PCR was performed 
with cDNA as template in 100/A with 15 pmol of each primer in 
1 × PCR buffer (0.067 M Tris, 0.166 M ammonium sulfate, 0.1 M 
fl-mercaptoethanol and 8% DMSO). An automated cykler (Perkin 
Elmer Cetus, Nowark) was used with the following program: 1 cylce 
of 95°C for 5 rain and 68°C for 5 min, followed by 35 cycles of 95°C 
for 1 min and 66°C for 5 min. In the last cycle, polymerization was for 
10 min at 74°C. PCR was started after the first denaturation step by 
addition of 5 units of recombinant Taq polymerase (Perkin Elmer 
Cetus, Nowark) and 0.5 units of Pfu polymerase (Stratagene, La Jolla). 
A band of approximately 800 basepairs was obtained in the 5'-RACE 
reactions and one of approximately 540 basepairs in the 3'-RACE 
reactions. Both fragments were reamplified using biotinylated adaptor 
primer and the s-1 or as-1 primer espectively. The PCR products were 
captured with streptavidin-coated magnetic beads (Dynal, Skojen) and 
direct sequencing of the PCR products was performed using the Prism 
Sequenase T rminator single-stranded DNA sequencing kit (Applied 
Biosystems). The products from the sequencing reactions were analysed 
on an Applied Biosystems 373A automated sequencer. In parallel, 
5'-and 3'-RACE products from the first PCR reactions were reampli- 
fled with non-biotinylated a aptor primer and the respective s nse or 
antisense primer. The reamplified products were gel-purified and 
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cloned into the TA-vector pCRII (InVitrogen, San Diego) as recom- 
mended by the supplier. Double-stranded plasmid DNA from four 5'- 
and four Y-clones was isolated and sequenced using the Prism Se- 
quenase Terminator double-stranded DNA sequencing kit (Applied 
Biosystems) and the automated sequencer. 
2.2. Tissue-specific expression 
Northern blotting was performed on a multiple tissue Northern blot 
filter (human MTN blot; Clonetech) as recommended bythe supplier. 
The probe used was a 832 basepair EcoRI fragment excised from one 
of the Y-RACE clones and spanning nucleotides -27 to +740 of the 
human clpP cDNA labelled by random hexamer labelling [16] using 
[32p]dCTP (Amersham). 
2.3. Chromosome localization 
Cell hybrid DNA from the NIGMS Human/Rodent Somatic Cell 
Hybrid Mapping Panel #1 were obtained from the NIGMS Human 
Genetic Mutant Cell Repository (Camden, N J). Restriction enzyme 
digestion of hybrid cell DNA, Southern transfer, and filter hybridiza- 
tion were carried out as described [17]. The clpP probe used was a 
restriction fragment comprising nucleotides 553 to the poly-A tail of the 
cDNA sequence. 
3. Results and discussion 
3.1. cDNA sequence 
Using the TFastA program of the GCG sequence analysis 
package (University of Wisconsin Genetics Computer Group) 
three overlapping human expressed sequence tags (EST's) 
which displayed considerable homology to the E. coli ClpP 
amino acid sequence were identified in the EMBL/GenBank 
databases. With primers situated in the region covered by the 
EST's, the RACE technique was used to amplify two overlap- 
ping fragments covering the whole cDNA of human clpP from 
placenta and fibroblast cDNA synthesized from mRNA or 
total RNA respectively. The PCR fragments were subjected to 
direct sequencing. In parallel, both fragments from amplified 
placenta cDNA were cloned into pCRII and eight selected 
clones were sequenced (four covering the 5'-end and four cov- 
ering the 3"-end). 
The sequencing data are summarized in Fig. 1. The sequence 
is 1044 basepairs long. It comprises a 19 basepair 5'-untrans- 
lated region, an open reading frame starting with an ATG start 
codon of 831 basepairs, and a 195 basepair long 3' untranslated 
region. The last two bases preceding the poly-A tail could not 
be determined unambiguously as the four 3'-clones contained 
variable sequences at these positions. This is probably due to 
the fact that the lock docking primer used for first strand 
cDNA synthesis carries degenerate nucleotides in the two last 
bases at the Y-end. 
3.2. ClpP amino acid sequence 
The human CIpP amino acid sequence deduced from the 
cDNA sequence comprises an 277 amino acid open reading 
frame starting with a methionine codon (Fig. 1). There is no 
other methionine codon within the first 87 amino acids suggest- 
ing that this is the authentic start codon. The first 59 amino 
acids preceding proline-60, which constitutes the first amino 
acid conserved in all known ClpP sequences ( ee below), have 
the characteristics of a mitochondrial transit peptide with the 
recurrent occurrence of arginine residues and the absence of 
negatively charged amino acids [18]. There are several potential 
cleavage sites for the mitochondrial processing protease three 
of which are marked in Fig. 1. 
19 GACC~GGGCGTGCGGA~G 1 
1 ATGTGGCCCGG~TATTGGTAG~GGGGCCCGGGT~CGTCATGCA~TACCCCGCGCTG 60 
2 M W P G I L  G C A  VA C R Y P A L  20 
61 GGGCCTCGCCTCGCCGCTCACTTTC~GCGCAGCGGCCGCCGCAGCGGACACTCCAGAAC 120 
2 1 G P R L A A  F P A  RP  Q R T ~ L Q N  40 
121 GGCCTGGCCCTGCAGCGGTGCCTG~CGCGACGGCGACCCGGGCTCTCCCGCTCATTCCC 180 
4 1 G L A L Q R C ~ L H A  A T R A ~ L ~ L I P  60 
181 ATCGTGGTGC, AGCAGACGGGTCGCGGCGAGCGCGCCTATGACATCTACTCGCGGCTGCTG 240 
6 / I V V E Q T G R G E  A Y D I Y  E L L  80 
241 CGGGAGCG~TCGTGTGCGTCATGGGCCCGATCGATGA~GCGTTGCCAGCCTTGTTATC 300 
8 / R E R I V C  M G P  D D S V A  L V I  i00 
301 GCACAGCTCCTCTTCCTGC~TCCGAGAGC~C~G~GCCCATCCACATGTACATC~C 360 
2 0 1 A Q L L F L Q S E $  K K P I H  Y I N  120 
361 AGCCCTGGTGGTGTGGTGACCGCGGGCCTGGCCATCTACGACACGATGCAGTACATCCTC 420 
1 2 3 S P G G V V  A G L  I Y D T M  Y I L  140 
421 ~CCCGATCTGCACCTGGTGCGTGGGCCAGGCCGCCAGCATGGGCTCCCTGCTTCTCGCC 480 
2 4 1 N P I C T W C V ~ O A A S M G S L L L A  160 
481 GCCGGCACCC~GGCATGCGCCACTCGCTCCCC~CTCCCGTATCATGATCCACCAGCCC 540 
1 6 1 A G T P G M R H S L P N S R I M  H O P  180 
541 TCAGGAGGC6CCCGGGGCC~GCCACAGA~TTGCCATC~GG~GAGGAGAT~TG~G 600 
1 8 1 S G G A R G Q A T D I A I Q A E  I M K  200 
601 CTC~G~G6AGCTCTAT~CATCTACGCC~G~CACC~ACAGAGCCTGCAGGTGAT6 660 
2 0 1 L K K Q L y N I Y A K M T K Q S  Q V I  220 
661 GAGTCCGC~TGGAGAG~ACCGCTACATGAGCCCCATGGAGGCCCAGGAGTTTGGCATC 720 
2 2 1 E S A M E R D R Y M S P M E A Q  F G I  240 
721 TTAGAC~GGTTCTGGTCCACCCTCCCCAGGACGGTGAG6ATGAGCCCACGCTGGTGCAG 780 
2 4 1 L D K V L V M P P Q D G E D E P  L V Q  260 
781 ~GGAGCCTGTAG~GCAG6GCCGGCAGCAG~CCTGTCCCAGCTAGCACCTGAGAGCTG 840 
2 6 1 K E P V E A A P A A E P V P A S  
841 ~CCTCCTCTC~G~TCATGT~AGGGG6CAGAGGCT~CCAGACCCCCAGCT~GCC6 900 
901 TGCTCACCCCTTGTTGCTGGGCTTGGAGGGGCCTCTTGA6G~CTTTT~TTTGCAGGG6 960 
961 TGCCCGCTATGGACGGGG~TTCCAGCTGAGACACTGTGATTTTAAATT~kATCTTTGTG 1020 
1021 GTCTT(nnaaaaaaaaa .... ) 
Fig. 1. cDNA sequence and deduced amino acid sequence of human 
clpR The numbering of nucleotides and amino acids start at the first 
residue of the coding sequence. The last two nucleotides preceding the 
poly-A tail determined by the cDNA synthesis primers and the start of 
the poly-A tail are shown in brackets (see text). The putative polyad- 
enylation site is underlined. The first amino acid (proline-60) conserved 
in all known ClpP sequences is denoted by a double underline. Three 
possible cleavage sites ~r  the mitochondrial processing protease are 
indicated by arrows. The consensus sequence around the catalytically 
active serine and histidine residues (in boldNce) are underlined and 
positions conserved in human CIpP are denoted with diamonds. 
Database search identified twelve full-length sequences with 
considerable homolgy to human ClpP: seven chloroplast en- 
coded ClpP's, three eubacterial ones and two others. The se- 
quences align well from proline-60 to aspartic acid 242 in 
human pre-ClpP. Both these residues are a fully conserved in 
all sequences. Only few short gaps have to be introduced. Align- 
ment of human ClpP with one representative each of the chlo- 
roplast and bacterial sequences and the two other ClpP se- 
quences is shown in Fig. 2. The 22 residues fully conserved in 
all thirteen ClpP sequences available to us are marked. Human 
CIpP displays highest homology towards ClpP from the nema- 
tode Ccenorhabditis elegans (C.e.; 58% identity), followed by the 
bacterial ClpP's (48-56% identity) and lowest toward chloro- 
plast ClpP (32-38% identity). The C.e. ClpP sequence in the 
database which originates from a genome sequencing project, 
predicts methionine 16 as the starting amino acid. If this were 
the case, the sequence would lack a mitochondrial leader pep- 
tide. However, there is another possible methionine start codon 
farther upstream which would result in a fifteen amino acids 
longer amino terminus as shown in Fig. 2. 
The percentage of identity of human ClpP towards ClpP 
from tomato (L.e.; 34%) is in the same range as that towards 
chloroplast CIpP. However, tomato CIpP displays slightly 
























l . . . . . . . . . . . . . . . . . . . . . . . . . .  MWPGILVGGARVASCRYPALGPRLAAHFPAQRPPQRTLQNGLALQRCLHAT 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  MLR LvTSS sAS SmS s 
1 MVTSAIAGTSIVPVSSPd4QTSFSSLLSSRSIRKNVVS LRSP  SDSSDIGFsSKKLGI  LKFNEYESG HTNSSYGV 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  MSYSGErDN 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
1 
52 ATRALPL IP IVVEQTGRGERAYDIYSRLLRERIVCVMGPIDDSVASLVIAQLLFLQSESNKKP IHMYINSPGGVVTA 
20 VQSRvG-  F idnE k t d 1 T v Fi A1 G S 
78 IVAKEGAN P IMPAVMTPVG L IS tV  F N iF iGQ vnSa  QK s vT  At IDENAD Li  1 C STYs 
12 F tPHmAv m i S sf k v iF iT  Qve  Hm N iv m ea NPE D Y1 i 
1 MP Igv  Kv  YR iPRDEEaTW-V 1 NVmY T IF IGQE RCE i tNHiTgLmvy SI DGISD Fl f  Wi I s  
78 P D R L N GG 
129 GLA IYDTMQYILNP ICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQPSGG-ARGQATDIA IQAEE IMKLKKQ 
96 i M SAvS V i  s C EK  Sa v - Q TCs  V R Tr  r 
155 V C SW KPKvG V F A Q a g EK  Yam a QS -CG HVE vRR VN AVQSrQK 
87 ms f KPDvS I m aF  t aK  K FC v L -YQ E H R 1 v GR 
77 m f TvTPD Y R 1 I a Fi  Lg  E TK  IaF Ha 1 aSaYY  aRtPeSL ieV  IH v rEM 
155 T . . .G .A .S . . .  G .R, . . . . . . .  M .HOP 
205 LYNIYAKHTKQSLQVIESAMERDRYMSPMEAQEFGILDKVLVHPPQDGEDEPTLVQKEPVEAAPAAEPVPAST*  
172 NE Vh  GM YDE Kt ld  f AH LK  iv  Q iET  NGSMPS * . . . . . . . . . . . . . . . . . . . . . . .  
231 vDKm AF  G iem qtYT  f SA  M li G ETEY*  . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
163 mNE1M L G eQ RDT f l  AP V y lv  S i  T R/q* . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
154 iTRv  Vr  GKPFW vSED Vf AD KAyE Iv  I GDEMIDKHC TDPvWFP MFKDW* . . . . . . . . . .  
conserved*  232 RD S E 
Fi!,'. 2. Alignment of ClpP sequences ( EMBL accession numbers in brackets). The human (H.s.: Z50853) CIpP amino acid sequence deduced from 
th~ eDNA sequence was aligned with CIpP from the nematode Caenorhabditis elegans (C.e.; Z49073), Lycopersieon eseulentum (L.e.; L38581), 
E~:heriehia coli (E.c.; J05534) and Triticum aestivum (T.ae.; X54484) using the pileup program (GCG package). Only differences in relation to the 
human sequence are shown. Gaps are indicated by hyphens. Conservative r placements are indicated by lower case letters. *The conserved residues 
gi~ en in the bottom line are those positions fully conserved inthe above four sequences and the following other ClpP sequences available in the 
da tabase: X04465, Z00044, X15901, L28807, D17510, L07793, UI6135 and X86563. The consensus sequences surrounding the catalytic histidine and 
se~ine r sidues are underlined and conserved positions given in boldface. A motif comprising the putative third residue in the catalytic triad (aspartic 
ac:d) is underlined. 
lower homology towards chloroplast ClpP's (3~34% identity) 
than towards bacterial ClpP's (3642% identity). It is therefore 
probable that the tomato ClpP as the Caenorhabditis elegans 
arid the human ClpP represents a mitochondrial C pP homolog. 
Although no significant homology of CIpP [12] towards clas- 
si,;al serine proteases can be observed, the proteolytic activity 
o~ the CIpP proteases appears to be accomplished by a charge 
relay system similar to that known for these enzymes with 
serine, histidine and aspartic acid forming the active site triad 
[12]. Consensus sequences surrounding two of the three cata- 
Ix tic residues in ClpP sequences have been identified (Prosite 
P';00381 and PS00382). As indicated in Fig. 1, these motifs are 
vesent in the human ClpP sequence confirming that it repre- 
stnts an authentic ClpP protease. Interestingly, the first residue 
iv the consensus sequence around the catalytically active histid- 
i~e residue is methionine in the three mitochondrial ClpP's 
hereas lysine is present at this position in all bacterial and 
cifloroplast sequences. This methionine r sidue may therefore 
b~' characteristic for mitochondrial CIpP sequences. The third 
rt~sidue in the catalytic triad in serine proteases i an aspartic 
a,id. There are three aspartic acid residues fully conserved in 
ail ClpP sequences. Two of these are located in a stretch of 
c,~nserved residues (residues 226-241 in human ClpP) close to 
t~e carboxyl end. This stretch may thus represent the motif 
c.)ntaining the third residue of the catalytic triad. Whether this 
i,. the case and which aspartic acid residue is involved has to 
l',e investigated by site-directed mutagenesis. 
From E. coli ClpP it is known that it cleaves offthe 14 amino 
t~:rminal residues autocatalytically [19]. The long amino termi- 
nal extensions ofhuman and tomato mitochondrial C pP's pre- 
ceding the homologous region would allow a two step process- 
lug, first by mitochondrial leader peptidase and then autocata- 
lytically. Whether this is the case has to be addressed experi- 
mentally. 





Fig. 3. Expression pattern of clpP in human tissues. A riP-labelled 
probe covering nucleotides -27 to 780 of the cDNA sequence was 
hybridized to a Multiple Tissue Northern blot as described insection 
2. The lenght of molecular weight standards in kilobases are given at 
the left margin. 
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3.3. Tissue specific expression 
A Northern blot filter with lanes containing similar quanti- 
ties of human mRNA from different issues was hybridized 
with a cDNA probe covering nucleotide positions -27 to +740 
of the cDNA sequence. As shown in Fig. 3, one specific band 
with an apparent length of approximately 1.35 kilobases was 
observed in all tissues analysed. This is in good agreement with 
the length of the cDNA assuming an approximately 150-200 
bases long poly-A tail. No other bands were detected indicating 
the presence of one single type of spliced transcript. The strong- 
est signal was observed in muscle tissue (skeletal muscle and 
heart). The order of decreasing intensity was: skeletal muscle 
> heart > liver and pancreas >brain, placenta, lung and kidney. 
The expression pattern is similar to that observed by Wang et 
al. for human Lon protease mRNA with the exception that 
relatively higher amounts of lon transcript were observed in 
brain and liver. Interestingly, the pattern for clpP mRNA 
matches with that for medium-chain a d very-long-chain acyl- 
CoA dehydrogenase (Brage S. Andresen, unpublished), two 
enzymes involved in the mitochondrial fl-oxidation of fatty 
acids. An involvement of ClpP in the degradation ofmisfolded 
intermediates of these proteins will be investigated. 
3.4. Chromosome localization 
DNA samples from 18 different human/rodent cell hybrids 
were analysed by Southern blotting using a cDNA probe com- 
prising nucleotides 553 to the poly-A tail. A human-specific 
signal was observed which allowed to assign the human clpP 
gene to chromosome 19. Strong cross-hybridization signals to- 
wards mouse and hamster DNA sequences were observed re- 
flecting the high conservation of clpP sequences between spe- 
cies. 
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